JP2009508916A5 - - Google Patents

Download PDF

Info

Publication number
JP2009508916A5
JP2009508916A5 JP2008531764A JP2008531764A JP2009508916A5 JP 2009508916 A5 JP2009508916 A5 JP 2009508916A5 JP 2008531764 A JP2008531764 A JP 2008531764A JP 2008531764 A JP2008531764 A JP 2008531764A JP 2009508916 A5 JP2009508916 A5 JP 2009508916A5
Authority
JP
Japan
Prior art keywords
composition according
solidified melt
paracetamol
melt particles
solidified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008531764A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009508916A (ja
Filing date
Publication date
Priority claimed from GBGB0519350.3A external-priority patent/GB0519350D0/en
Application filed filed Critical
Publication of JP2009508916A publication Critical patent/JP2009508916A/ja
Publication of JP2009508916A5 publication Critical patent/JP2009508916A5/ja
Pending legal-status Critical Current

Links

JP2008531764A 2005-09-22 2006-09-07 Ｎｓａｉｄとパラセタモールを含んだ組成物 Pending JP2009508916A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0519350.3A GB0519350D0 (en) 2005-09-22 2005-09-22 Therapeutic agents
PCT/GB2006/003297 WO2007034135A1 (en) 2005-09-22 2006-09-07 Composition comprising a nsaid and paracetamol

Publications (2)

Publication Number Publication Date
JP2009508916A JP2009508916A (ja) 2009-03-05
JP2009508916A5 true JP2009508916A5 (enExample) 2009-10-22

Family

ID=35335274

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008531764A Pending JP2009508916A (ja) 2005-09-22 2006-09-07 Ｎｓａｉｄとパラセタモールを含んだ組成物

Country Status (13)

Country Link
US (1) US20090142392A1 (enExample)
EP (2) EP2851068B1 (enExample)
JP (1) JP2009508916A (enExample)
KR (2) KR20130141728A (enExample)
CN (1) CN101267807B (enExample)
AU (1) AU2006293798B2 (enExample)
CA (1) CA2623281A1 (enExample)
GB (1) GB0519350D0 (enExample)
PL (2) PL1926477T3 (enExample)
RU (1) RU2438656C2 (enExample)
SG (1) SG149080A1 (enExample)
WO (1) WO2007034135A1 (enExample)
ZA (1) ZA200802436B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080275125A1 (en) 2004-07-07 2008-11-06 Aft Pharmaceuticals Limited Combination Composition
GB2447898B (en) * 2007-03-24 2011-08-17 Reckitt Benckiser Healthcare A tablet having improved stability with at least two actives
KR20100134557A (ko) * 2008-01-11 2010-12-23 씨아이피엘에이 엘티디. 고체 약제학적 투여 제형
WO2009128543A1 (ja) * 2008-04-17 2009-10-22 ニプロ株式会社 シリカを含む錠剤の製造方法、錠剤及び錠剤用複合粒子
AU2009304002B9 (en) * 2008-10-14 2014-06-26 Aft Pharmaceuticals Limited A medicinal product and treatment
ES2365961B1 (es) * 2010-03-30 2013-01-24 Farmasierra Manufacturing S.L. Formulación farmacéutica a base de ibuprofeno y codeína de estabilidad mejorada.
CN105816434B (zh) * 2016-04-19 2019-09-17 山东新华制药股份有限公司 布洛芬颗粒及其制备方法
EP3700509B1 (en) 2017-11-29 2023-11-22 Ilko Ilaç Sanayi Ve Ticaret Anonim Sirketi Color stable fixed dose tablet combination of ibuprofen and paracetamol
US20190350883A1 (en) * 2018-05-20 2019-11-21 Luan Chau Pharmaceutical Composition of Acetaminophen/Ibuprofen
US11197830B2 (en) 2019-02-27 2021-12-14 Aft Pharmaceuticals Limited Pharmaceutical composition containing acetaminophen and ibuprofen
US11779541B2 (en) 2019-03-26 2023-10-10 Johnson & Johnson Consumer Inc. Immediate release dosage form
AU2020301401B2 (en) 2019-06-27 2023-12-21 Glaxosmithkline Consumer Healthcare Holdings (Us) Llc Novel ibuprofen and acetaminophen composition
CN110372713B (zh) * 2019-08-15 2022-05-17 广州市汉普医药有限公司 一种普拉洛芬的精制纯化方法
WO2023281089A2 (en) 2021-07-08 2023-01-12 Krka, D.D., Novo Mesto Pharmaceutical composition comprising naproxen and paracetamol

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5271811A (en) * 1988-01-29 1993-12-21 Hoechst Celanese Corporation Process for purifying 2-(4-isobutylphenyl)-propionic acid by vacuum distillation
DE3802619C1 (enExample) 1988-01-29 1989-09-07 Hoechst Ag, 6230 Frankfurt, De
DE3833448A1 (de) 1988-10-01 1990-04-12 Hoechst Ag Verfahren zur gewinnung von ibuprofen fuer die direkttablettierung
US5409709A (en) * 1991-11-29 1995-04-25 Lion Corporation Antipyretic analgesic preparation containing ibuprofen
JP3122748B2 (ja) * 1991-11-29 2001-01-09 ライオン株式会社 イブプロフェン含有解熱鎮痛剤
DE4418837A1 (de) * 1994-05-30 1995-12-07 Bayer Ag Thermisches Granulierverfahren
DE4446468A1 (de) * 1994-12-23 1996-06-27 Basf Ag Verfahren zur Herstellung von umhüllten Tabletten
JP3982889B2 (ja) * 1997-11-28 2007-09-26 あすか製薬株式会社 イブプロフェン含有医薬製剤
US6787157B1 (en) * 1998-03-10 2004-09-07 Abbott Laboratories Multiphase active ingredient-containing formulations
RU2192248C2 (ru) * 1998-07-13 2002-11-10 Товарищество с ограниченной ответственностью фирма "Эйкос" Препарат "антигриппин"
HK1046644B (en) * 1999-12-09 2006-11-10 Reckitt Benckiser Healthcare (Uk) Limited Compressed tablet composition comprising a nsaid
GB0113841D0 (en) 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
RU2237470C1 (ru) * 2003-01-27 2004-10-10 Купсин Евгений Вениаминович Комбинированный препарат для устранения симптомов простудных заболеваний и гриппа (варианты)
US20040265378A1 (en) * 2003-06-25 2004-12-30 Yingxu Peng Method and compositions for producing granules containing high concentrations of biologically active substances
JP2008509206A (ja) * 2004-08-12 2008-03-27 レキット ベンキーザー ヘルスケア （ユーケイ） リミテッド 溶融押出しにより作製するｎｓａｉｄ及び糖アルコールを含む顆粒
GB0423103D0 (en) * 2004-10-19 2004-11-17 Boots Healthcare Int Ltd Therapeutic agents

Similar Documents

Publication Publication Date Title
JP2009508916A5 (enExample)
JP2003516341A5 (enExample)
JP2009536147A5 (enExample)
JP2009500443A5 (enExample)
CN101073563B (zh) 一种含有右旋布洛芬和左旋西替利嗪的手性组合物及其缓速释双层片
JP2008520736A5 (enExample)
WO2010103544A3 (en) A novel sustained release composition of compounds selected from the class of centrally acting muscle relaxants
JP2009543885A5 (enExample)
WO2007012019A3 (en) Medicaments containing famotidine and ibuprofen and administration of same
JP2006527256A5 (enExample)
JP2009517411A5 (enExample)
JP2013541583A5 (enExample)
CA2576652A1 (en) Granules comprising paracetamol, a nsaid and a sugar alcohol made by melt extrusion
EA200901146A1 (ru) Твердые лекарственные формы, содержащие алискирен и его фармацевтически приемлемые соли
KR101466331B1 (ko) 적어도 2개의 활성 성분으로 안정성이 개량된 정제
HRP20161470T1 (hr) Smjese flurbiprofena s kontroliranim otpuštanjem i mišićnog relaksanta
JP2011506587A5 (enExample)
JP2005533751A5 (enExample)
RU2008115507A (ru) Композиция, включающая нпвс и парацетамол
CA2797551A1 (en) Melt-granulated fingolimod
CN103120688A (zh) 一种闪释制剂的药物组合
JP2006503095A5 (enExample)
CN101856338A (zh) 枸橼酸钾缓释丸剂
JP2014012660A (ja) ロキソプロフェン含有医薬組成物
JP2008534523A5 (enExample)